IL13RA2 and neoplasm: Recent years, IL-13Rα2, a so-called decoy receptor [22, 23], has been shown to be highly expressed in many tumor types, such as head and neck, glioblastoma and lung [24–26], and was also shown to promote invasion and metastasis of colorectal, ovarian and pancreatic cancers [27–29].